3D Global Biotech Inc. (TPEX:6808)

Taiwan · Delayed Price · Currency is TWD

30.65

-0.35 (-1.13%)

May 8, 2026, 1:48 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Medical Products	206.74M	265.69M	20.63M	13.64M	11.08M
Medical Products Growth	-22.19%	1187.68%	51.24%	23.19%	-16.48%
Total	206.74M	265.69M	20.63M	13.64M	11.08M
Total Growth	-22.19%	1187.68%	51.24%	23.19%	-16.48%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Taiwan	147.39M	134.24M	20.63M	13.64M	11.08M
Taiwan Growth	9.80%	550.62%	51.24%	23.19%	-16.48%
China	-	108.74M	-	-	-
United State	59.34M	22.70M	-	-	-
United State Growth	161.41%	-	-	-	-
Total	206.74M	265.69M	20.63M	13.64M	11.08M
Total Growth	-22.19%	1187.68%	51.24%	23.19%	-16.48%

Source: S&P Global Market Intelligence.